Lhasa Limited shared knowledge shared progress
  • Publisher:
    Lhasa Limited and FDA
  • Publication Date:
    Apr 2014
  • Reference:
  • DOI:
  • PMID:
  • Publication Type:
  • Related Products:
  • Scientific Area:
  • Endpoint:
  • Industry Type:
  • Related event:

FDA/CDER Current Practices for (Q)SAR Analysis under ICH M7.pdf

pdf fileKruhlak NL;

Naomi Kruhlak of the Food and Drug Administration presents on the proposed ICH M7 guidelines. The presentation provides an overview of (Q)SAR models and methods used at FDA/CDER for the prediction of bacterial mutagenicity, including specific expert analysis steps applied.

Presented by Naomi Kruhlak as part of the 2014 virtual ICGM series; 16th April 2014.


© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.